missing translation for 'onlineSavingsMsg'
Learn More
Learn More
beta 2-Microglobulin Antibody (B2M/961), PE/Cy7, Novus Biologicals™
Mouse Monoclonal Antibody
Marque: Novus Biologicals NBP2-47704PECY7
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
beta 2-Microglobulin Monoclonal specifically detects beta 2-Microglobulin in Human, Primate samples. It is validated for Flow Cytometry.
Spécification
| beta 2-Microglobulin | |
| Monoclonal | |
| PE-Cyanine7 | |
| PBS with 0.05% Sodium Azide | |
| B2M | |
| Full length recombinant human beta 2-Microglobulin protein (Uniprot: P61769 ) | |
| 0.1 mL | |
| Primary | |
| Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. | |
| Store at 4°C in the dark. Do not freeze. |
| Flow Cytometry | |
| B2M/961 | |
| Flow Cytometry | |
| beta chain of MHC class I molecules, beta-2-microglobin, beta-2-microglobulin | |
| Mouse | |
| Protein A or G purified | |
| Adaptive Immunity, Cancer, Cell Biology, Diabetes Research, Immunology | |
| 567.0 | |
| Human, Primate | |
| IgG2b κ |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu